VeinTech

Every day, millions of IVs are placed in patients around the world. And a large share of first attempts don't succeed. A 25-country survey of 712 patients and caregivers found first-attempt insertion failed in 40% of adults and 64% of children. (Cooke et al., PLOS ONE, 2018) We talk about this like it's an operational hiccup. It isn't. 👤 Patients Over half of adults in the survey rated insertion as moderately painful or worse. For children, repeated attempts meant repeated needle sticks — and repeated distress. 🩺 Clinicians Every failed attempt means trying again, reassuring an increasingly anxious patient, and time pulled away from other care. 🏥 Hospitals Failed insertions mean more staff time, more supplies used, and delayed starts to treatment. This is never "just" an IV. #VascularAccess #PatientSafety #HealthTech #Nursing

Great to see VeinTech represented at St Catherine's College's Faculty & Industry Dinner, "Bench to Bedside" 🩺 Ellaby Hansen and Peter Carr joined fellow founders, researchers and industry leaders to share the journey from MedTech research to patient outcomes, alongside representatives from other incredible companies, including fellow Herdsman MedTech Innovation Hub members CoraMetix and Earflo. It's always energising to connect with the next generation of students exploring the world of medical technology in Western Australia. Thanks for having us, St Catherine's College!

Congratulations to our CEO and Co-Founder, Nikhilesh Bappoo, on being named a finalist for the 2026 AmCham Australia Alliance Awards in the Life Sciences category. The Alliance Awards recognise emerging and exceptional leaders shaping the economic and technological partnership between Australia and the US, and it's a fantastic honour to see Nik's work recognised in this way. Congratulations to all the finalists, and thank you to AmCham Australia for the recognition.

Yesterday, members of the VeinTech team had the opportunity to attend the Life Sciences WA Women in Life Sciences event. It was an inspiring afternoon celebrating the incredible women driving innovation across Western Australia’s life sciences sector. From research and clinical care to entrepreneurship and commercialisation, the event showcased the depth of talent and leadership helping shape the future of healthcare. A big thank you to Life Sciences WA for bringing together such a fantastic community including amazing panelists and speakers throughout the event. We’re proud to support initiatives that foster collaboration, champion diversity and strengthen the life sciences ecosystem. Here’s to continuing to build a sector where great ideas and great people can thrive.

We're incredibly proud to share that VeinTech has been named a Top 5 Finalist for the Outstanding Patient Innovation Award in the 2026 Patients' Choice Awards! Patients Australia At VeinTech, everything we do starts with one goal: improving outcomes for patients. Being recognised for our work to make vascular access more accessible, equitable and successful is an honour, and a reflection of the clinicians, patients, researchers and partners who have helped shape our technology along the way. A huge thank you to Patients Australia for this recognition, and to everyone who supported us through the nomination and public voting process. We're honoured to stand alongside so many organisations making a meaningful difference to patient care across Australia. #PatientsChoiceAwards2026 #PatientsAustralia #PatientVoice

🎉 We're thrilled to share that VeinTech has been nominated for Outstanding Patient Innovation at the Patient's Choice Awards 2026, sponsored by Medibank! This recognition reflects our commitment to improving patient experiences through better vascular access solutions, and we couldn't be prouder to be in the running. If you believe in what we're building, we'd love your vote 🙌 🗳️ Vote now: https://lnkd.in/g7A4XceM Thank you to Patients Australia, Chiesi Australia, and Medibank for championing patient-centred innovation across Australia. #PatientsChoiceAwards2026 #OutstandingPatientInnovation

Great things happening on the world stage 🌏 Our CEO and Co-Founder Nikhilesh Bappoo joined the "Needs First Innovation: Born from Biodesign" panel at the LSI Asia Summit in Singapore, sharing the stage with fellow Western Australian representatives Kevin Pfleger Intan Oldakowska and Oliver Bazzani to discuss how biodesign thinking drives medtech from unmet clinical need to real-world impact. Proud to see WA's medtech ecosystem so well represented on the international stage. Thank you to the LSI team for the opportunity! #LSIAsia26 #Biodesign

At VeinTech, we're used to pushing for better healthcare outcomes every day - but over the past few weeks, we've been putting that commitment to the test in a slightly different way.   Together with our friends and fellow innovators at the Herdsman MedTech Innovation Hub, we've been counting push-ups, encouraging each other, and raising awareness for mental health through this year's The Push-Up Challenge.   Over the past few weeks, we've swapped desks for push-ups, challenged each other to keep moving, and helped raise awareness and support for mental health across Australia. Whether it was squeezing in push-ups between meetings, turning friendly competition into motivation, or simply showing up each day, the challenge has been a great reminder that looking after our health includes both body and mind.   A huge congratulations to everyone at the Hub who got involved. Safe to say there might be a few sore arms around the hub this week 💪   Donate to the Herdsman MedTech Innovation Hub team here: https://lnkd.in/gDdpxmEV lubdub.ai Earflo CoraMetix

Excited to share that our CEO and Co-Founder, Nikhilesh Bappoo, will be joining fellow Australian medtech leaders on the "Needs-First, Market-Ready: Innovations Born from Biodesign" panel at LSI Asia '26 in Singapore. 📍 Catch the session Wednesday, July 1 at 10:30 AM, Banyan room, Shangri-La Singapore. #LSIAsia26

What a fantastic night at the VeinTech Investor Showcase.   It was a pleasure to welcome both existing and prospective shareholders to our headquarters at the Herdsman MedTech Innovation Hub for a celebration and an exclusive insight into VeinTech's latest achievements!   One of the highlights of the evening was unveiling our latest device design, giving attendees an exclusive first look at the next step in our product development journey. We were also fortunate to have Gavin Jackson, lead vascular access CNC at South Metropolitan Health Services, share his personal insignts into the potential impact VeinTech could have on vascular access procedures and patient care and to also provide a live demonstration of the technology in action!   Thank you to everyone who attended and continues to support our mission. We're excited about what lies ahead and look forward to sharing more milestones as we continue to advance towards commercialisation. Peter Traianou Nikhilesh Bappoo Peter Carr